Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jun;103(2):1453-7.
doi: 10.1111/j.1476-5381.1991.tb09810.x.

Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle

Affiliations

Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle

R Carrón et al. Br J Pharmacol. 1991 Jun.

Abstract

1. In rat isolated aorta the class Ic antiarrhythmic drug, propafenone, dose-dependently inhibited the contractile responses induced by high K (80 mM) and noradrenaline (NA, 10(-5) M), the IC50s being 2.5 +/- 0.7 x 10(-6) M and 8.7 +/- 0.8 x 10(-6) M, respectively. These inhibitory actions were also observed with propafenone added after the induced contractions. 2. Contractile responses induced by addition of Ca to 0 Ca high-K solution were also inhibited by propafenone (IC50 = 2.5 +/- 0.8 x 10(-6) M). Moreover, propafenone inhibited the contractile responses elicited by NA in strips incubated in 0 Ca (IC50 = 1.9 +/- 0.9 x 10(-6) M). 3. Propafenone also inhibited (IC50 = 1.2 +/- 0.4 x 10(-5) M) the development of spontaneous mechanical activity in portal vein segments. 4. Propafenone, 5 x 10(-6) M and 10(-5) M, inhibited 45Ca uptake stimulated by high K or NA without altering 45Ca uptake in resting strips. 5. These results indicated that in rat isolated aortae and portal veins propafenone inhibited Ca entry through voltage-operated channels and NA-induced Ca uptake as well as Ca release from intracellular stores. As a consequence it would reduce the concentration of intracellular free Ca available at the contractile apparatus for vascular smooth muscle contraction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Rev. 1986 Dec;38(4):321-416 - PubMed
    1. Acta Physiol Scand. 1975 Nov;95(3):263-9 - PubMed
    1. J Pharm Pharmacol. 1984 Aug;36(8):521-6 - PubMed
    1. Am J Cardiol. 1984 Nov 14;54(9):13D-19D - PubMed
    1. Drugs. 1987 Dec;34(6):617-47 - PubMed

Publication types